Amid Flat Q4 Array Sales, Agilent Plans New Expression Chips for 2010

While the overall market for gene-expression arrays has plateaued, Agilent is looking to attract new customers by enhancing the performance of its chips and reducing cost per sample.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.